| Symbol | NVCR |
|---|---|
| Name | NOVOCURE LTD |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | NO. 4 THE FORUM, ST. HELIER, None None |
| Telephone | 44 (0)15 3475 6700 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001645113 |
| Description | None |
(10% Negative) NOVOCURE LTD (NVCR) Announces Delay in observed Trials for locally Due to Regulatory Process, Manufacturing Considerations, Safety Review
Read moreNovocure’s Optune Pax® Receives CE Mark for the Treatment of Locally Advanced Pancreatic Cancer
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR
Read moreNVCR Investors Have Opportunity to Join NovoCure Limited Fraud Investigation with the Schall Law Firm
Read moreNovocure Announces Topline Data from the Phase 3 TRIDENT Trial Evaluating Earlier Use of Tumor Treating Fields Therapy in Newly Diagnosed Glioblastoma
Read moreLeonard Frank X 🔴 sold 34.3K shares of NovoCure Ltd (NVCR) at $17.93 Transaction Date: Jun 04, 2026 | Filing ID: 000004
Read moreLEUNG GABRIEL 🟢 acquired 28.6K shares (1 derivative) of NovoCure Ltd (NVCR) at $16.15 Transaction Date: Jun 03, 2026 | Filing ID: 000002
Read more